°µ¿°æÈñ´ëÇб³º´¿ø Á¦16ȸ ´ëÇѽÅÀåÇÐȸ Ç÷¾×Åõ¼®¿©°ú¿¬±¸È¸ ¿¬¼ö°Á : 2019-11-17±³À°ÀÏÀÚ : 2019-11-17
±³À°Àå¼Ò : °µ¿°æÈñ´ëÇб³º´¿ø º°°ü ÁöÇÏ1Ãþ °´ç
±³À°ÁÖÁ¦ :
Á¦16ȸ ´ëÇѽÅÀåÇÐȸ Ç÷¾×Åõ¼®¿©°ú¿¬±¸È¸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷¾×Åõ¼®¿©°ú¹ý ¿¬±¸È¸
´ã´çÀÚ : ±èÁöÀº
¿¬¶ôó : 02-440-8149
À̸ÞÀÏ :
neoim00@nate.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í ÀÇ»ç(Àü¹®ÀÇ) : »çÀü 20,000¿ø ÇöÀå 30,000¿ø / Àü°øÀÇ, °£È£»ç : »çÀü 10,000¿ø ÇöÀå 15,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-17 °´ç 08:30~08:50 ±¹³»¿Ü HDFÀÇ ÇöȲ (Current status of HDF) ÀÌÀ¯È£(Ä¡ÀÇ°ú´ë)
±³À°½Ã°£ 11-17 °´ç 08:50~09:15 ¾ó¸¶³ª HDF´Â »ç¸Á·üÀ» °³¼±½ÃÅ°´Â°¡? (The recent updates of survival data in OL-HDF) Á¶¿µÀÏ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-17 °´ç 09:15~09:55 ¾î¶»°Ô HDF´Â »ç¸Á·üÀ» °³¼±½ÃÅ°´Â°¡? (Mechanism of survival benefit of OL-HDF) BernardCanaud(University of Montpellier France)
Åä·Ð 11-17 °´ç 09:55~10:05 ÅäÀÇ ÀÌÀ¯È£ Á¶¿µÀÏ BernardCanaud()
±³À°½Ã°£ 11-17 °´ç 10:15~10:40 Áø·á ÇöÀå¿¡¼ HDFÀÇ Ã³¹æÀÇ ½ÇÁ¦ (HDF prescription in real-world) À̼ҿµ(Â÷ÀÇ°ú´ë)
±³À°½Ã°£ 11-17 °´ç 10:40~11:05 High convection volumeÀ» ¸¸Á·Çϱâ À§ÇØ ¾î¶»°Ô ÇØ¾ß Çϳª? (Maintenance of high voume HDF) ¹®ÁÖ¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-17 °´ç 11:05~11:35 Online HDF °£È£ÀÇ A to Z (Nursing care for OL-HDF: From A to Z) °¹®ÀÚ(°µ¿°æÈñ´ëº´¿ø Àΰø½ÅÀå½Ç)
Åä·Ð 11-17 °´ç 11:35~11:45 ÅäÀÇ À̼ҿµ ¹®ÁÖ¿µ °¹®ÀÚ()
±³À°½Ã°£ 11-17 °´ç 12:00~12:25 ±¸¿¬»ê Åõ¼®¾×ÀÇ È¿°ú (Citrate vs Acetate dialysate) Á¤¼ö¿õ(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-17 °´ç 12:25~12:55 Expanded HD (HDx with MCO membrane) °¼±¿ì(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-17 °´ç 12:55~13:20 Åõ¼® ȯÀÚ¿Í ¿µ¾ç (Nutritional updates in diaysis) ¾È¿ø¼®(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11-17 °´ç 13:20~13:45 Åõ¼® ȯÀÚÀÇ ºÎ°©»ó¼± Ç×ÁøÁõ Ä¡·á (Vitamin D vs Cinacalcet vs Parathyroidectomy) ±è⼺(Àü³²ÀÇ´ë)
Åä·Ð 11-17 °´ç 13:45~13:55 ÅäÀÇ Á¤¼ö¿õ °¼±¿ì ¾È¿ø¼® ±è⼺()